nodes	percent_of_prediction	percent_of_DWPC	metapath
Metronidazole—Abdominal distress—Metformin—polycystic ovary syndrome	0.138	0.142	CcSEcCtD
Metronidazole—Taste metallic—Metformin—polycystic ovary syndrome	0.0587	0.0604	CcSEcCtD
Metronidazole—Gastrointestinal tract irritation—Metformin—polycystic ovary syndrome	0.0523	0.0538	CcSEcCtD
Metronidazole—Emotional distress—Metformin—polycystic ovary syndrome	0.0439	0.0452	CcSEcCtD
Metronidazole—Abdominal bloating—Metformin—polycystic ovary syndrome	0.0392	0.0404	CcSEcCtD
Metronidazole—Loose stools—Metformin—polycystic ovary syndrome	0.0337	0.0347	CcSEcCtD
Metronidazole—Fungal infection—Metformin—polycystic ovary syndrome	0.0242	0.0249	CcSEcCtD
Metronidazole—Blood disorder—Metformin—polycystic ovary syndrome	0.0224	0.023	CcSEcCtD
Metronidazole—Neuropathy—Metformin—polycystic ovary syndrome	0.0175	0.018	CcSEcCtD
Metronidazole—Nasal congestion—Metformin—polycystic ovary syndrome	0.0149	0.0153	CcSEcCtD
Metronidazole—Liver function test abnormal—Metformin—polycystic ovary syndrome	0.0125	0.0129	CcSEcCtD
Metronidazole—Abdominal pain upper—Metformin—polycystic ovary syndrome	0.0124	0.0127	CcSEcCtD
Metronidazole—Breast disorder—Metformin—polycystic ovary syndrome	0.0123	0.0126	CcSEcCtD
Metronidazole—Cramp muscle—Metformin—polycystic ovary syndrome	0.0122	0.0126	CcSEcCtD
Metronidazole—Nasopharyngitis—Metformin—polycystic ovary syndrome	0.0121	0.0125	CcSEcCtD
Metronidazole—Abdominal distension—Metformin—polycystic ovary syndrome	0.0118	0.0121	CcSEcCtD
Metronidazole—Influenza—Metformin—polycystic ovary syndrome	0.0117	0.0121	CcSEcCtD
Metronidazole—Pancreatitis—Metformin—polycystic ovary syndrome	0.0115	0.0118	CcSEcCtD
Metronidazole—Abdominal discomfort—Metformin—polycystic ovary syndrome	0.0112	0.0116	CcSEcCtD
Metronidazole—Neutropenia—Metformin—polycystic ovary syndrome	0.011	0.0113	CcSEcCtD
Metronidazole—Upper respiratory tract infection—Metformin—polycystic ovary syndrome	0.0109	0.0112	CcSEcCtD
Metronidazole—Infestation NOS—Metformin—polycystic ovary syndrome	0.0105	0.0107	CcSEcCtD
Metronidazole—Infestation—Metformin—polycystic ovary syndrome	0.0105	0.0107	CcSEcCtD
Metronidazole—Drowsiness—Metformin—polycystic ovary syndrome	0.0105	0.0107	CcSEcCtD
Metronidazole—Neuropathy peripheral—Metformin—polycystic ovary syndrome	0.0102	0.0105	CcSEcCtD
Metronidazole—Hepatobiliary disease—Metformin—polycystic ovary syndrome	0.00988	0.0102	CcSEcCtD
Metronidazole—Rhinitis—Metformin—polycystic ovary syndrome	0.0094	0.00967	CcSEcCtD
Metronidazole—Hepatitis—Metformin—polycystic ovary syndrome	0.00938	0.00965	CcSEcCtD
Metronidazole—Hypoaesthesia—Metformin—polycystic ovary syndrome	0.00933	0.0096	CcSEcCtD
Metronidazole—Connective tissue disorder—Metformin—polycystic ovary syndrome	0.00922	0.00948	CcSEcCtD
Metronidazole—Eye disorder—Metformin—polycystic ovary syndrome	0.00877	0.00902	CcSEcCtD
Metronidazole—Flushing—Metformin—polycystic ovary syndrome	0.00871	0.00895	CcSEcCtD
Metronidazole—Cardiac disorder—Metformin—polycystic ovary syndrome	0.00871	0.00895	CcSEcCtD
Metronidazole—Angiopathy—Metformin—polycystic ovary syndrome	0.00851	0.00875	CcSEcCtD
Metronidazole—Immune system disorder—Metformin—polycystic ovary syndrome	0.00847	0.00871	CcSEcCtD
Metronidazole—Mediastinal disorder—Metformin—polycystic ovary syndrome	0.00845	0.0087	CcSEcCtD
Metronidazole—Erythema—Metformin—polycystic ovary syndrome	0.00817	0.0084	CcSEcCtD
Metronidazole—Flatulence—Metformin—polycystic ovary syndrome	0.00805	0.00828	CcSEcCtD
Metronidazole—Dysgeusia—Metformin—polycystic ovary syndrome	0.008	0.00822	CcSEcCtD
Metronidazole—Muscle spasms—Metformin—polycystic ovary syndrome	0.00785	0.00807	CcSEcCtD
Metronidazole—Vision blurred—Metformin—polycystic ovary syndrome	0.0077	0.00792	CcSEcCtD
Metronidazole—Tremor—Metformin—polycystic ovary syndrome	0.00765	0.00787	CcSEcCtD
Metronidazole—Malaise—Metformin—polycystic ovary syndrome	0.00736	0.00757	CcSEcCtD
Metronidazole—Syncope—Metformin—polycystic ovary syndrome	0.00732	0.00753	CcSEcCtD
Metronidazole—Palpitations—Metformin—polycystic ovary syndrome	0.00722	0.00742	CcSEcCtD
Metronidazole—Loss of consciousness—Metformin—polycystic ovary syndrome	0.00718	0.00738	CcSEcCtD
Metronidazole—Hypertension—Metformin—polycystic ovary syndrome	0.00705	0.00725	CcSEcCtD
Metronidazole—Chest pain—Metformin—polycystic ovary syndrome	0.00695	0.00715	CcSEcCtD
Metronidazole—Unspecified disorder of skin and subcutaneous tissue—Metformin—polycystic ovary syndrome	0.0069	0.0071	CcSEcCtD
Metronidazole—Oedema—Metformin—polycystic ovary syndrome	0.00666	0.00685	CcSEcCtD
Metronidazole—Infection—Metformin—polycystic ovary syndrome	0.00662	0.00681	CcSEcCtD
Metronidazole—Shock—Metformin—polycystic ovary syndrome	0.00656	0.00674	CcSEcCtD
Metronidazole—Nervous system disorder—Metformin—polycystic ovary syndrome	0.00654	0.00672	CcSEcCtD
Metronidazole—Thrombocytopenia—Metformin—polycystic ovary syndrome	0.00653	0.00671	CcSEcCtD
Metronidazole—Skin disorder—Metformin—polycystic ovary syndrome	0.00647	0.00666	CcSEcCtD
Metronidazole—Hyperhidrosis—Metformin—polycystic ovary syndrome	0.00644	0.00663	CcSEcCtD
Metronidazole—Anorexia—Metformin—polycystic ovary syndrome	0.00635	0.00653	CcSEcCtD
Metronidazole—Musculoskeletal discomfort—Metformin—polycystic ovary syndrome	0.00607	0.00625	CcSEcCtD
Metronidazole—Paraesthesia—Metformin—polycystic ovary syndrome	0.00598	0.00616	CcSEcCtD
Metronidazole—Somnolence—Metformin—polycystic ovary syndrome	0.00593	0.00609	CcSEcCtD
Metronidazole—Dyspepsia—Metformin—polycystic ovary syndrome	0.00587	0.00603	CcSEcCtD
Metronidazole—Decreased appetite—Metformin—polycystic ovary syndrome	0.00579	0.00596	CcSEcCtD
Metronidazole—Gastrointestinal disorder—Metformin—polycystic ovary syndrome	0.00575	0.00592	CcSEcCtD
Metronidazole—Fatigue—Metformin—polycystic ovary syndrome	0.00575	0.00591	CcSEcCtD
Metronidazole—Constipation—Metformin—polycystic ovary syndrome	0.0057	0.00586	CcSEcCtD
Metronidazole—Feeling abnormal—Metformin—polycystic ovary syndrome	0.00549	0.00565	CcSEcCtD
Metronidazole—Gastrointestinal pain—Metformin—polycystic ovary syndrome	0.00545	0.00561	CcSEcCtD
Metronidazole—Urticaria—Metformin—polycystic ovary syndrome	0.00529	0.00545	CcSEcCtD
Metronidazole—Abdominal pain—Metformin—polycystic ovary syndrome	0.00527	0.00542	CcSEcCtD
Metronidazole—Asthenia—Metformin—polycystic ovary syndrome	0.00478	0.00492	CcSEcCtD
Metronidazole—Pruritus—Metformin—polycystic ovary syndrome	0.00472	0.00485	CcSEcCtD
Metronidazole—Diarrhoea—Metformin—polycystic ovary syndrome	0.00456	0.00469	CcSEcCtD
Metronidazole—Dizziness—Metformin—polycystic ovary syndrome	0.00441	0.00453	CcSEcCtD
Metronidazole—Vomiting—Metformin—polycystic ovary syndrome	0.00424	0.00436	CcSEcCtD
Metronidazole—Rash—Metformin—polycystic ovary syndrome	0.0042	0.00432	CcSEcCtD
Metronidazole—Dermatitis—Metformin—polycystic ovary syndrome	0.0042	0.00432	CcSEcCtD
Metronidazole—Headache—Metformin—polycystic ovary syndrome	0.00418	0.00429	CcSEcCtD
Metronidazole—Nausea—Metformin—polycystic ovary syndrome	0.00396	0.00407	CcSEcCtD
Metronidazole—CYP3A4—Benzo(a)pyrene metabolism—AKR1C2—polycystic ovary syndrome	0.00149	0.0539	CbGpPWpGaD
Metronidazole—CYP3A4—Benzo(a)pyrene metabolism—AKR1C1—polycystic ovary syndrome	0.00083	0.03	CbGpPWpGaD
Metronidazole—CYP2C8—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1A1—polycystic ovary syndrome	0.000822	0.0297	CbGpPWpGaD
Metronidazole—CYP2C8—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1A1—polycystic ovary syndrome	0.000748	0.027	CbGpPWpGaD
Metronidazole—CYP2C8—Tamoxifen metabolism—SULT2A1—polycystic ovary syndrome	0.000723	0.0261	CbGpPWpGaD
Metronidazole—CYP2C9—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1A1—polycystic ovary syndrome	0.000669	0.0242	CbGpPWpGaD
Metronidazole—CYP3A4—Benzo(a)pyrene metabolism—AKR1C3—polycystic ovary syndrome	0.000639	0.0231	CbGpPWpGaD
Metronidazole—CYP2C9—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1A1—polycystic ovary syndrome	0.000609	0.022	CbGpPWpGaD
Metronidazole—CYP2C9—Tamoxifen metabolism—SULT2A1—polycystic ovary syndrome	0.000588	0.0213	CbGpPWpGaD
Metronidazole—CYP3A4—Drug Induction of Bile Acid Pathway—SULT2A1—polycystic ovary syndrome	0.000459	0.0166	CbGpPWpGaD
Metronidazole—CYP3A4—Farnesoid X Receptor  Pathway—SULT2A1—polycystic ovary syndrome	0.00042	0.0152	CbGpPWpGaD
Metronidazole—CYP2C9—Constitutive Androstane Receptor Pathway—SULT2A1—polycystic ovary syndrome	0.00042	0.0152	CbGpPWpGaD
Metronidazole—CYP3A4—Benzo(a)pyrene metabolism—CYP1A1—polycystic ovary syndrome	0.000401	0.0145	CbGpPWpGaD
Metronidazole—CYP2C8—Xenobiotics—CYP1A1—polycystic ovary syndrome	0.000395	0.0143	CbGpPWpGaD
Metronidazole—CYP3A4—Tamoxifen metabolism—SULT2A1—polycystic ovary syndrome	0.000388	0.014	CbGpPWpGaD
Metronidazole—CYP2C8—Tamoxifen metabolism—CYP1A1—polycystic ovary syndrome	0.00038	0.0137	CbGpPWpGaD
Metronidazole—CYP2C9—Xenobiotics—CYP1A1—polycystic ovary syndrome	0.000321	0.0116	CbGpPWpGaD
Metronidazole—CYP2C9—Tamoxifen metabolism—CYP1A1—polycystic ovary syndrome	0.000309	0.0112	CbGpPWpGaD
Metronidazole—CYP2C8—Arachidonic acid metabolism—AKR1C3—polycystic ovary syndrome	0.000302	0.0109	CbGpPWpGaD
Metronidazole—CYP3A4—Constitutive Androstane Receptor Pathway—SULT2A1—polycystic ovary syndrome	0.000277	0.01	CbGpPWpGaD
Metronidazole—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP11A1—polycystic ovary syndrome	0.000276	0.00999	CbGpPWpGaD
Metronidazole—CYP2C8—Oxidation by Cytochrome P450—CYP11A1—polycystic ovary syndrome	0.000273	0.00986	CbGpPWpGaD
Metronidazole—CYP2C8—Metapathway biotransformation—AKR1C2—polycystic ovary syndrome	0.000259	0.00936	CbGpPWpGaD
Metronidazole—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP17A1—polycystic ovary syndrome	0.000257	0.00929	CbGpPWpGaD
Metronidazole—CYP2C8—Oxidation by Cytochrome P450—CYP17A1—polycystic ovary syndrome	0.000254	0.00916	CbGpPWpGaD
Metronidazole—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—polycystic ovary syndrome	0.000253	0.00915	CbGpPWpGaD
Metronidazole—CYP2C9—Arachidonic acid metabolism—AKR1C3—polycystic ovary syndrome	0.000246	0.00888	CbGpPWpGaD
Metronidazole—CYP3A4—Estrogen metabolism—CYP1A1—polycystic ovary syndrome	0.000231	0.00833	CbGpPWpGaD
Metronidazole—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP11A1—polycystic ovary syndrome	0.000225	0.00813	CbGpPWpGaD
Metronidazole—CYP2C8—Phase 1 - Functionalization of compounds—CYP11A1—polycystic ovary syndrome	0.000224	0.0081	CbGpPWpGaD
Metronidazole—CYP2C9—Oxidation by Cytochrome P450—CYP11A1—polycystic ovary syndrome	0.000222	0.00802	CbGpPWpGaD
Metronidazole—CYP3A4—Xenobiotics—CYP1A1—polycystic ovary syndrome	0.000212	0.00766	CbGpPWpGaD
Metronidazole—CYP2C9—Metapathway biotransformation—AKR1C2—polycystic ovary syndrome	0.000211	0.00761	CbGpPWpGaD
Metronidazole—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP17A1—polycystic ovary syndrome	0.000209	0.00756	CbGpPWpGaD
Metronidazole—CYP2C8—Phase 1 - Functionalization of compounds—CYP17A1—polycystic ovary syndrome	0.000208	0.00753	CbGpPWpGaD
Metronidazole—CYP2C9—Oxidation by Cytochrome P450—CYP17A1—polycystic ovary syndrome	0.000206	0.00746	CbGpPWpGaD
Metronidazole—CYP3A4—Tamoxifen metabolism—CYP1A1—polycystic ovary syndrome	0.000204	0.00736	CbGpPWpGaD
Metronidazole—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP19A1—polycystic ovary syndrome	0.000203	0.00735	CbGpPWpGaD
Metronidazole—CYP2C8—Oxidation by Cytochrome P450—CYP19A1—polycystic ovary syndrome	0.000201	0.00725	CbGpPWpGaD
Metronidazole—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—polycystic ovary syndrome	0.000196	0.00708	CbGpPWpGaD
Metronidazole—CYP2C8—Arachidonic acid metabolism—CYP1A1—polycystic ovary syndrome	0.00019	0.00685	CbGpPWpGaD
Metronidazole—CYP2C9—Phase 1 - Functionalization of compounds—CYP11A1—polycystic ovary syndrome	0.000182	0.00659	CbGpPWpGaD
Metronidazole—CYP2C9—Phase 1 - Functionalization of compounds—CYP17A1—polycystic ovary syndrome	0.00017	0.00613	CbGpPWpGaD
Metronidazole—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP19A1—polycystic ovary syndrome	0.000166	0.00598	CbGpPWpGaD
Metronidazole—CYP2C8—Phase 1 - Functionalization of compounds—CYP19A1—polycystic ovary syndrome	0.000165	0.00596	CbGpPWpGaD
Metronidazole—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP1A1—polycystic ovary syndrome	0.000164	0.00592	CbGpPWpGaD
Metronidazole—CYP2C9—Oxidation by Cytochrome P450—CYP19A1—polycystic ovary syndrome	0.000163	0.0059	CbGpPWpGaD
Metronidazole—CYP2C8—Oxidation by Cytochrome P450—CYP1A1—polycystic ovary syndrome	0.000162	0.00585	CbGpPWpGaD
Metronidazole—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—polycystic ovary syndrome	0.000159	0.00574	CbGpPWpGaD
Metronidazole—CYP2C9—Arachidonic acid metabolism—CYP1A1—polycystic ovary syndrome	0.000154	0.00558	CbGpPWpGaD
Metronidazole—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP11A1—polycystic ovary syndrome	0.000148	0.00536	CbGpPWpGaD
Metronidazole—CYP3A4—Oxidation by Cytochrome P450—CYP11A1—polycystic ovary syndrome	0.000146	0.00529	CbGpPWpGaD
Metronidazole—CYP2C8—Metapathway biotransformation—AKR1C1—polycystic ovary syndrome	0.000144	0.0052	CbGpPWpGaD
Metronidazole—CYP3A4—Metapathway biotransformation—AKR1C2—polycystic ovary syndrome	0.000139	0.00502	CbGpPWpGaD
Metronidazole—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP17A1—polycystic ovary syndrome	0.000138	0.00498	CbGpPWpGaD
Metronidazole—CYP3A4—Oxidation by Cytochrome P450—CYP17A1—polycystic ovary syndrome	0.000136	0.00492	CbGpPWpGaD
Metronidazole—CYP3A4—Tryptophan metabolism—CYP19A1—polycystic ovary syndrome	0.000135	0.00488	CbGpPWpGaD
Metronidazole—CYP2C8—Biological oxidations—SULT2A1—polycystic ovary syndrome	0.000134	0.00486	CbGpPWpGaD
Metronidazole—CYP2C9—Phase 1 - Functionalization of compounds—CYP19A1—polycystic ovary syndrome	0.000134	0.00485	CbGpPWpGaD
Metronidazole—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1A1—polycystic ovary syndrome	0.000133	0.00482	CbGpPWpGaD
Metronidazole—CYP2C8—Phase 1 - Functionalization of compounds—CYP1A1—polycystic ovary syndrome	0.000133	0.0048	CbGpPWpGaD
Metronidazole—CYP2C8—Metapathway biotransformation—SULT2A1—polycystic ovary syndrome	0.000133	0.00479	CbGpPWpGaD
Metronidazole—CYP2C9—Oxidation by Cytochrome P450—CYP1A1—polycystic ovary syndrome	0.000132	0.00476	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism of lipids and lipoproteins—LPCAT2—polycystic ovary syndrome	0.000128	0.00461	CbGpPWpGaD
Metronidazole—CYP2C8—Cytochrome P450 - arranged by substrate type—POMC—polycystic ovary syndrome	0.000122	0.00442	CbGpPWpGaD
Metronidazole—CYP3A4—Phase 1 - Functionalization of compounds—CYP11A1—polycystic ovary syndrome	0.00012	0.00435	CbGpPWpGaD
Metronidazole—CYP2C8—Biological oxidations—CYP11A1—polycystic ovary syndrome	0.000119	0.0043	CbGpPWpGaD
Metronidazole—CYP2C8—Metapathway biotransformation—CYP11A1—polycystic ovary syndrome	0.000117	0.00424	CbGpPWpGaD
Metronidazole—CYP2C9—Metapathway biotransformation—AKR1C1—polycystic ovary syndrome	0.000117	0.00424	CbGpPWpGaD
Metronidazole—CYP3A4—Phase 1 - Functionalization of compounds—CYP17A1—polycystic ovary syndrome	0.000112	0.00404	CbGpPWpGaD
Metronidazole—CYP2C8—Metapathway biotransformation—AKR1C3—polycystic ovary syndrome	0.000111	0.00401	CbGpPWpGaD
Metronidazole—CYP2C8—Biological oxidations—CYP17A1—polycystic ovary syndrome	0.000111	0.004	CbGpPWpGaD
Metronidazole—CYP2C9—Biological oxidations—SULT2A1—polycystic ovary syndrome	0.000109	0.00395	CbGpPWpGaD
Metronidazole—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—polycystic ovary syndrome	0.000109	0.00394	CbGpPWpGaD
Metronidazole—CYP2C8—Metapathway biotransformation—CYP17A1—polycystic ovary syndrome	0.000109	0.00394	CbGpPWpGaD
Metronidazole—CYP3A4—Tryptophan metabolism—CYP1A1—polycystic ovary syndrome	0.000109	0.00393	CbGpPWpGaD
Metronidazole—CYP2C9—Phase 1 - Functionalization of compounds—CYP1A1—polycystic ovary syndrome	0.000108	0.00391	CbGpPWpGaD
Metronidazole—CYP2C9—Metapathway biotransformation—SULT2A1—polycystic ovary syndrome	0.000108	0.0039	CbGpPWpGaD
Metronidazole—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—polycystic ovary syndrome	0.000108	0.00389	CbGpPWpGaD
Metronidazole—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—polycystic ovary syndrome	0.000105	0.00379	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism of lipids and lipoproteins—LPCAT2—polycystic ovary syndrome	0.000104	0.00375	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism of lipids and lipoproteins—AKR1C2—polycystic ovary syndrome	0.000101	0.00364	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism of lipids and lipoproteins—TEAD2—polycystic ovary syndrome	0.000101	0.00364	CbGpPWpGaD
Metronidazole—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—polycystic ovary syndrome	9.95e-05	0.00359	CbGpPWpGaD
Metronidazole—CYP2C8—Phase 1 - Functionalization of compounds—POMC—polycystic ovary syndrome	9.91e-05	0.00358	CbGpPWpGaD
Metronidazole—CYP2C9—Biological oxidations—CYP11A1—polycystic ovary syndrome	9.69e-05	0.0035	CbGpPWpGaD
Metronidazole—CYP2C9—Metapathway biotransformation—CYP11A1—polycystic ovary syndrome	9.56e-05	0.00345	CbGpPWpGaD
Metronidazole—CYP2C9—Metapathway biotransformation—AKR1C3—polycystic ovary syndrome	9.02e-05	0.00326	CbGpPWpGaD
Metronidazole—CYP2C9—Biological oxidations—CYP17A1—polycystic ovary syndrome	9.01e-05	0.00325	CbGpPWpGaD
Metronidazole—CYP2C9—Metapathway biotransformation—CYP17A1—polycystic ovary syndrome	8.88e-05	0.00321	CbGpPWpGaD
Metronidazole—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—polycystic ovary syndrome	8.85e-05	0.0032	CbGpPWpGaD
Metronidazole—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—polycystic ovary syndrome	8.8e-05	0.00318	CbGpPWpGaD
Metronidazole—CYP2C8—Biological oxidations—CYP19A1—polycystic ovary syndrome	8.76e-05	0.00316	CbGpPWpGaD
Metronidazole—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—polycystic ovary syndrome	8.68e-05	0.00314	CbGpPWpGaD
Metronidazole—CYP2C8—Metapathway biotransformation—CYP19A1—polycystic ovary syndrome	8.64e-05	0.00312	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism of lipids and lipoproteins—PNPLA2—polycystic ovary syndrome	8.45e-05	0.00305	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism of lipids and lipoproteins—TEAD2—polycystic ovary syndrome	8.21e-05	0.00296	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C2—polycystic ovary syndrome	8.21e-05	0.00296	CbGpPWpGaD
Metronidazole—CYP2C9—Phase 1 - Functionalization of compounds—POMC—polycystic ovary syndrome	8.07e-05	0.00291	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism of lipids and lipoproteins—SRD5A1—polycystic ovary syndrome	8.01e-05	0.00289	CbGpPWpGaD
Metronidazole—CYP3A4—Metapathway biotransformation—AKR1C1—polycystic ovary syndrome	7.73e-05	0.00279	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism of lipids and lipoproteins—STAR—polycystic ovary syndrome	7.64e-05	0.00276	CbGpPWpGaD
Metronidazole—CYP3A4—Biological oxidations—SULT2A1—polycystic ovary syndrome	7.21e-05	0.00261	CbGpPWpGaD
Metronidazole—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—polycystic ovary syndrome	7.13e-05	0.00258	CbGpPWpGaD
Metronidazole—CYP2C9—Biological oxidations—CYP19A1—polycystic ovary syndrome	7.13e-05	0.00258	CbGpPWpGaD
Metronidazole—CYP3A4—Metapathway biotransformation—SULT2A1—polycystic ovary syndrome	7.11e-05	0.00257	CbGpPWpGaD
Metronidazole—CYP2C8—Biological oxidations—CYP1A1—polycystic ovary syndrome	7.06e-05	0.00255	CbGpPWpGaD
Metronidazole—CYP2C9—Metapathway biotransformation—CYP19A1—polycystic ovary syndrome	7.03e-05	0.00254	CbGpPWpGaD
Metronidazole—CYP2C8—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	6.96e-05	0.00252	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism of lipids and lipoproteins—PNPLA2—polycystic ovary syndrome	6.88e-05	0.00248	CbGpPWpGaD
Metronidazole—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—polycystic ovary syndrome	6.56e-05	0.00237	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism of lipids and lipoproteins—SRD5A1—polycystic ovary syndrome	6.52e-05	0.00236	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism of lipids and lipoproteins—HSD3B1—polycystic ovary syndrome	6.5e-05	0.00235	CbGpPWpGaD
Metronidazole—CYP3A4—Biological oxidations—CYP11A1—polycystic ovary syndrome	6.39e-05	0.00231	CbGpPWpGaD
Metronidazole—CYP3A4—Metapathway biotransformation—CYP11A1—polycystic ovary syndrome	6.3e-05	0.00228	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism of lipids and lipoproteins—STAR—polycystic ovary syndrome	6.22e-05	0.00225	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—NMNAT3—polycystic ovary syndrome	6.21e-05	0.00224	CbGpPWpGaD
Metronidazole—CYP3A4—Metapathway biotransformation—AKR1C3—polycystic ovary syndrome	5.95e-05	0.00215	CbGpPWpGaD
Metronidazole—CYP3A4—Biological oxidations—CYP17A1—polycystic ovary syndrome	5.94e-05	0.00215	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism of lipids and lipoproteins—LHB—polycystic ovary syndrome	5.92e-05	0.00214	CbGpPWpGaD
Metronidazole—CYP3A4—Metapathway biotransformation—CYP17A1—polycystic ovary syndrome	5.86e-05	0.00212	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism of lipids and lipoproteins—HSD3B2—polycystic ovary syndrome	5.79e-05	0.00209	CbGpPWpGaD
Metronidazole—CYP2C9—Biological oxidations—CYP1A1—polycystic ovary syndrome	5.75e-05	0.00208	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—SUOX—polycystic ovary syndrome	5.68e-05	0.00205	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—LPCAT2—polycystic ovary syndrome	5.68e-05	0.00205	CbGpPWpGaD
Metronidazole—CYP2C9—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	5.67e-05	0.00205	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism of lipids and lipoproteins—AKR1C1—polycystic ovary syndrome	5.61e-05	0.00203	CbGpPWpGaD
Metronidazole—CYP3A4—Phase 1 - Functionalization of compounds—POMC—polycystic ovary syndrome	5.32e-05	0.00192	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism of lipids and lipoproteins—HSD3B1—polycystic ovary syndrome	5.29e-05	0.00191	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—ISYNA1—polycystic ovary syndrome	5.28e-05	0.00191	CbGpPWpGaD
Metronidazole—CYP2C8—Biological oxidations—POMC—polycystic ovary syndrome	5.26e-05	0.0019	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism of lipids and lipoproteins—SULT2A1—polycystic ovary syndrome	5.16e-05	0.00186	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—NMNAT3—polycystic ovary syndrome	5.05e-05	0.00183	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism of lipids and lipoproteins—LHB—polycystic ovary syndrome	4.82e-05	0.00174	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism of lipids and lipoproteins—YAP1—polycystic ovary syndrome	4.82e-05	0.00174	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism of lipids and lipoproteins—HSD3B2—polycystic ovary syndrome	4.71e-05	0.0017	CbGpPWpGaD
Metronidazole—CYP3A4—Biological oxidations—CYP19A1—polycystic ovary syndrome	4.7e-05	0.0017	CbGpPWpGaD
Metronidazole—CYP3A4—Metapathway biotransformation—CYP19A1—polycystic ovary syndrome	4.64e-05	0.00168	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—LPCAT2—polycystic ovary syndrome	4.62e-05	0.00167	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—SUOX—polycystic ovary syndrome	4.62e-05	0.00167	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism of lipids and lipoproteins—CYP11A1—polycystic ovary syndrome	4.57e-05	0.00165	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C1—polycystic ovary syndrome	4.56e-05	0.00165	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—AKR1C2—polycystic ovary syndrome	4.49e-05	0.00162	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—TEAD2—polycystic ovary syndrome	4.49e-05	0.00162	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	4.32e-05	0.00156	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—ISYNA1—polycystic ovary syndrome	4.3e-05	0.00155	CbGpPWpGaD
Metronidazole—CYP2C9—Biological oxidations—POMC—polycystic ovary syndrome	4.28e-05	0.00155	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	4.25e-05	0.00154	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism of lipids and lipoproteins—SULT2A1—polycystic ovary syndrome	4.2e-05	0.00152	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism of lipids and lipoproteins—YAP1—polycystic ovary syndrome	3.92e-05	0.00142	CbGpPWpGaD
Metronidazole—CYP3A4—Biological oxidations—CYP1A1—polycystic ovary syndrome	3.79e-05	0.00137	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—PNPLA2—polycystic ovary syndrome	3.76e-05	0.00136	CbGpPWpGaD
Metronidazole—CYP3A4—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	3.74e-05	0.00135	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism of lipids and lipoproteins—CYP11A1—polycystic ovary syndrome	3.72e-05	0.00134	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—AKR1C2—polycystic ovary syndrome	3.65e-05	0.00132	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—TEAD2—polycystic ovary syndrome	3.65e-05	0.00132	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—SRD5A1—polycystic ovary syndrome	3.57e-05	0.00129	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	3.51e-05	0.00127	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	3.46e-05	0.00125	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—STAR—polycystic ovary syndrome	3.4e-05	0.00123	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	3.36e-05	0.00122	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—NMNAT3—polycystic ovary syndrome	3.33e-05	0.0012	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—PNPLA2—polycystic ovary syndrome	3.06e-05	0.00111	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—SUOX—polycystic ovary syndrome	3.05e-05	0.0011	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—LPCAT2—polycystic ovary syndrome	3.05e-05	0.0011	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—HMMR—polycystic ovary syndrome	3.03e-05	0.0011	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—SRD5A1—polycystic ovary syndrome	2.9e-05	0.00105	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—HSD3B1—polycystic ovary syndrome	2.89e-05	0.00105	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	2.86e-05	0.00103	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—ISYNA1—polycystic ovary syndrome	2.83e-05	0.00102	CbGpPWpGaD
Metronidazole—CYP3A4—Biological oxidations—POMC—polycystic ovary syndrome	2.83e-05	0.00102	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—STAR—polycystic ovary syndrome	2.77e-05	0.001	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	2.74e-05	0.000989	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	2.71e-05	0.00098	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—LHB—polycystic ovary syndrome	2.64e-05	0.000953	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—HSD3B2—polycystic ovary syndrome	2.58e-05	0.000932	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—AKR1C1—polycystic ovary syndrome	2.5e-05	0.000902	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—HMMR—polycystic ovary syndrome	2.47e-05	0.000892	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—TEAD2—polycystic ovary syndrome	2.41e-05	0.000871	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—AKR1C2—polycystic ovary syndrome	2.41e-05	0.000871	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—HSD3B1—polycystic ovary syndrome	2.35e-05	0.000851	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	2.33e-05	0.000841	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—SULT2A1—polycystic ovary syndrome	2.3e-05	0.00083	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—RRM2—polycystic ovary syndrome	2.23e-05	0.000804	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	2.21e-05	0.000797	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—LHB—polycystic ovary syndrome	2.15e-05	0.000776	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—YAP1—polycystic ovary syndrome	2.15e-05	0.000775	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—HSD3B2—polycystic ovary syndrome	2.1e-05	0.000758	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—NAMPT—polycystic ovary syndrome	2.06e-05	0.000745	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	2.05e-05	0.000741	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—CYP11A1—polycystic ovary syndrome	2.04e-05	0.000736	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—AKR1C1—polycystic ovary syndrome	2.03e-05	0.000734	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	2.02e-05	0.00073	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—PNPLA2—polycystic ovary syndrome	2.02e-05	0.00073	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—AKR1C3—polycystic ovary syndrome	1.92e-05	0.000695	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—SRD5A1—polycystic ovary syndrome	1.91e-05	0.000692	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—CYP17A1—polycystic ovary syndrome	1.89e-05	0.000684	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—SULT2A1—polycystic ovary syndrome	1.87e-05	0.000676	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—STAR—polycystic ovary syndrome	1.83e-05	0.00066	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—RRM2—polycystic ovary syndrome	1.81e-05	0.000655	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—YAP1—polycystic ovary syndrome	1.75e-05	0.000631	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—NAMPT—polycystic ovary syndrome	1.68e-05	0.000606	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	1.67e-05	0.000603	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—CYP11A1—polycystic ovary syndrome	1.66e-05	0.000599	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	1.65e-05	0.000594	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—TH—polycystic ovary syndrome	1.64e-05	0.000592	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—HMMR—polycystic ovary syndrome	1.63e-05	0.000588	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—SLC2A4—polycystic ovary syndrome	1.59e-05	0.000576	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—AKR1C3—polycystic ovary syndrome	1.56e-05	0.000565	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—HSD3B1—polycystic ovary syndrome	1.55e-05	0.000561	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—CYP17A1—polycystic ovary syndrome	1.54e-05	0.000557	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—CYP19A1—polycystic ovary syndrome	1.5e-05	0.000541	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—LHB—polycystic ovary syndrome	1.42e-05	0.000512	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—HSD3B2—polycystic ovary syndrome	1.38e-05	0.0005	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—AKR1C1—polycystic ovary syndrome	1.34e-05	0.000484	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—GNAS—polycystic ovary syndrome	1.34e-05	0.000483	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—TH—polycystic ovary syndrome	1.33e-05	0.000482	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—SLC2A4—polycystic ovary syndrome	1.3e-05	0.000468	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—NCOR1—polycystic ovary syndrome	1.27e-05	0.00046	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—SULT2A1—polycystic ovary syndrome	1.23e-05	0.000446	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—CYP19A1—polycystic ovary syndrome	1.22e-05	0.00044	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—CYP1A1—polycystic ovary syndrome	1.21e-05	0.000436	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—RRM2—polycystic ovary syndrome	1.19e-05	0.000432	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—YAP1—polycystic ovary syndrome	1.15e-05	0.000416	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—MTHFR—polycystic ovary syndrome	1.13e-05	0.000407	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—NAMPT—polycystic ovary syndrome	1.11e-05	0.0004	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—CYP11A1—polycystic ovary syndrome	1.09e-05	0.000395	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—GNAS—polycystic ovary syndrome	1.09e-05	0.000393	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—NCOR1—polycystic ovary syndrome	1.04e-05	0.000375	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—AKR1C3—polycystic ovary syndrome	1.03e-05	0.000373	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—CYP17A1—polycystic ovary syndrome	1.02e-05	0.000367	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—CYP1A1—polycystic ovary syndrome	9.83e-06	0.000355	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—MTHFR—polycystic ovary syndrome	9.16e-06	0.000331	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—PPARG—polycystic ovary syndrome	9.13e-06	0.00033	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—POMC—polycystic ovary syndrome	9e-06	0.000325	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—INS—polycystic ovary syndrome	8.95e-06	0.000323	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—TH—polycystic ovary syndrome	8.79e-06	0.000318	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—SLC2A4—polycystic ovary syndrome	8.55e-06	0.000309	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—CYP19A1—polycystic ovary syndrome	8.04e-06	0.00029	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—PPARG—polycystic ovary syndrome	7.43e-06	0.000268	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—POMC—polycystic ovary syndrome	7.33e-06	0.000265	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—INS—polycystic ovary syndrome	7.29e-06	0.000263	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—GNAS—polycystic ovary syndrome	7.18e-06	0.000259	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—NCOR1—polycystic ovary syndrome	6.84e-06	0.000247	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—CYP1A1—polycystic ovary syndrome	6.48e-06	0.000234	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—MTHFR—polycystic ovary syndrome	6.04e-06	0.000218	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—PPARG—polycystic ovary syndrome	4.9e-06	0.000177	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—POMC—polycystic ovary syndrome	4.83e-06	0.000175	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—INS—polycystic ovary syndrome	4.81e-06	0.000174	CbGpPWpGaD
